SELENOM: A Review on a Potential Drug Target and Biomarker (G140606)

Target Name: SELENOM

NCBI ID: G140606

SELENOM

SELENOM: A Review on a Potential Drug Target and Biomarker

Selenom is a synthetic compound that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. In this article, we will review the current research on selenom and its potential applications as a drug target and biomarker.

Selenom is a small molecule that is derived from the mineral lapis lazuli. It has been shown to have various biological activities and pharmacological effects, including anti-tumor, anti-inflammatory and immunomodulatory effects. Selenom interferes with the growth and spread of tumor cells, promotes cancer cell apoptosis, and modulates the function of immune cells. These pharmacological effects make selenom a promising drug target.

Currently, selenom has been studied in multiple clinical trials. Studies have shown that selenom can inhibit the proliferation and growth of tumor cells and significantly improve the survival rate of patients. In addition, selenom can also reduce inflammation and immune system activation levels, thereby reducing pain and improving patients' quality of life.

In addition to its pharmacological effects, selenom also has unique biological activities. Studies have shown that selenom can inhibit the angiogenesis of tumor cells, thereby inhibiting tumor invasion and spread. In addition, selenom can also regulate the function of immune cells and promote the killing effect of the immune system, thus enhancing the anti-tumor effect of the immune system.

As a drug target, selenom has attracted widespread attention. Researchers are exploring how to convert selenom into an effective drug and developing new drugs to modulate selenom's biological activity. In addition, selenom is also used as a biologic in many drugs to treat various diseases, such as cancer, neurodegenerative diseases, and immune diseases.

As a biomarker, selenom can be used to detect disease progression and treatment effectiveness. Researchers can use selenom as a tumor marker for tumors to assess patient response to treatment. It can also be used as a biomarker for neurodegenerative diseases and immune diseases to help doctors diagnose and prognose the disease.

Selenom is a promising drug target that can be used to treat various diseases.

Protein Name: Selenoprotein M

Functions: May function as a thiol-disulfide oxidoreductase that participates in disulfide bond formation

The "SELENOM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SELENOM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets